The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Interleukin-6 and cachexia in ApcMin/+mice
Abstract
The Apc Min/+mouse has a mutation in the Apc tumor suppressor gene and develops intestinal polyps, beginning at 4 wk of age. This mouse develops cachexia by 6 mo, characterized by significant loss of muscle and fat tissue. The purpose of the present study was to determine the role of circulating interleukin-6 (IL-6) and the polyp burden for the development of cachexia in Apc Min/+mice. At 26 wk of age, mice exhibiting severe cachectic symptoms had a 61% decrease in gastrocnemius muscle weight, complete loss of epididymal fat, a 10-fold increase in circulating IL-6 levels, and an 89% increase in intestinal polyps compared with mildly cachectic animals. Apc Min/+/IL-6−/−mice did not lose gastrocnemius muscle mass or epididymal fat pad mass while overall polyp number decreased by 32% compared with Apc Min/+mice. Plasmid-based IL-6 overexpression in Apc Min/+/IL-6−/−mice led to a decrease in gastrocnemius muscle mass and epididymal fat pad mass and increased intestinal polyp burden. IL-6 overexpression did not induce cachexia in non-tumor-bearing mice. These data demonstrate that IL-6 is necessary for the onset of adipose and skeletal muscle wasting in the Apc Min/+mouse and that circulating IL-6 can regulate Apc Min/+mouse tumor burden.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · cited 3×
“Ligation of this receptor activates signal transducers and activators of transcription (STAT-3) (9, 11, 20), which is generally associated with cell growth, differentiation, development, and survival (6).”
A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591
Interleukin-6-deficient mice develop mature-onset obesity
Wallenius, V., Wallenius, K., Ahrén, B., Rudling, M., Carlsten, H., Dickson, S. L., Ohlsson, C., & Jansson, J.-O. (2002) · Nature Medicine · doi:10.1038/nm0102-75 · Cited by 1,213 · cited 2×
“Although the association between high circulating IL-6 levels and muscle wasting has been demonstrated previously (21, 38, 40, 45), the current study shows that even low, chronic levels of IL-6 are associated with muscle mass loss.”
Tisdale, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc927 · Cited by 982
SOCS3 negatively regulates IL-6 signaling in vivo
Croker, B. A., Krebs, D. L., Zhang, J.-G., Wormald, S., Willson, T. A., Stanley, E. G., Robb, L., Greenhalgh, C. J., Förster, I., Clausen, B. E., et al. (2003) · Nature Immunology · doi:10.1038/ni931 · Cited by 840
IL-6 signal transduction and its physiological roles: the signal orchestration model
Kamimura, D., Ishihara, K., & Hirano, T. (2003) · Reviews of Physiology, Biochemistry and Pharmacology · doi:10.1007/s10254-003-0012-2 · Cited by 673
Evidence for the involvement of interleukin 6 in experimental cancer cachexia.
Strassmann, G., Fong, M., Kenney, J. S., & Jacob, C. O. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115767 · Cited by 658
IL-6-induced skeletal muscle atrophy
Haddad, F., Zaldivar, F., Cooper, D. M., & Adams, G. R. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01026.2004 · Cited by 612
Tsujinaka, T., Fujita, J., Ebisui, C., Yano, M., Kominami, E., Suzuki, K., Tanaka, K., Katsume, A., Ohsugi, Y., Shiozaki, H., et al. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118398 · Cited by 421 · cited 2×
“These data coincide with other models of cachexia showing that blocking the effects of IL-6 have positive effects on skeletal muscle mass (14, 35, 39, 44).”
The Role of STATs in Apoptosis
Battle, T., & Frank, D. (2002) · Current Molecular Medicine · doi:10.2174/1566524023362456 · Cited by 284
Signaling Specificity of Interleukin-6 Action on Glucose and Lipid Metabolism in Skeletal Muscle
Al-Khalili, L., Bouzakri, K., Glund, S., Lönnqvist, F., Koistinen, H. A., & Krook, A. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0490 · Cited by 250
Karni, R., Jove, R., & Levitzki, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202835 · Cited by 242
Interleukin-6 Directly Increases Glucose Metabolism in Resting Human Skeletal Muscle
Glund, S., Deshmukh, A., Long, Y. C., Moller, T., Koistinen, H. A., Caidahl, K., Zierath, J. R., & Krook, A. (2007) · Diabetes · doi:10.2337/db06-1733 · Cited by 219
Aging-sensitive cellular and molecular mechanisms associated with skeletal muscle hypertrophy
Haddad, F., & Adams, G. R. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01227.2005 · Cited by 179
Khalfoun, B., Thibault, F., Watier, H., BARDOS, P., & Lebranchu, Y. (1997) · PubMed · Cited by 170
Cytokines in the pathogenesis of cancer cachexia
Argilés, J. M., Busquets, S., & López-Soriano, F. J. (2003) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000078983.18774.cc · Cited by 165
Tsujinaka, T., Ebisui, C., Fujita, J., Kishibuchi, M., Morimoto, T., Ogawa, A., Katsume, A., Ohsugi, Y., Kominami, E., & Monden, M. (1995) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1006/bbrc.1995.1168 · Cited by 159
Duval, D., Reinhardt, B., Kédinger, C., & Bœuf, H. (2000) · The FASEB Journal · doi:10.1096/fj.14.11.1577 · Cited by 149
Fujita, J., Tsujinaka, T., Jano, M., Ebisui, C., Saito, H., Katsume, A., Akamatsu, K., Ohsugi, Y., Shiozaki, H., & Monden, M. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961127)68:5<637::aid-ijc14>3.0.co;2-z · Cited by 146
Cancer-Induced Fatigue and Skeletal Muscle Wasting: The Role of Exercise
Al‐Majid, S., & McCarthy, D. O. (2001) · Biological Research For Nursing · doi:10.1177/109980040100200304 · Cited by 146
CNTO 328, a monoclonal antibody to IL‐6, inhibits human tumor‐induced cachexia in nude mice
Zaki, M. H., Nemeth, J. A., & Trikha, M. (2004) · International Journal of Cancer · doi:10.1002/ijc.20270 · Cited by 126
Fenton, J. I., Hursting, S. D., Perkins, S. N., & Hord, N. G. (2006) · Carcinogenesis · doi:10.1093/carcin/bgl018 · Cited by 102
Tisdale, M. J. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-002-0408-6 · Cited by 100
Decreased intestinal polyp multiplicity is related to exercise mode and gender in ApcMin/+ mice
Mehl, K. A., Davis, J. M., Clements, J. M., Berger, F. G., Pena, M. M., & Carson, J. A. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00975.2004 · Cited by 99 · cited 3×
“Polyp counts were performed as described previously (29).”
Self-citationSteiner, H., Godoy‐Tundidor, S., Rogatsch, H., Berger, A. P., Fuchs, D., Comuzzi, B., Bartsch, G. H., Hobisch, A., & Čulig, Z. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63859-x · Cited by 97
Weigert, C., Hennige, A. M., Brodbeck, K., Häring, H. U., & Schleicher, E. D. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00448.2004 · Cited by 95
Kami, K., & Senba, E. (2002) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540205001202 · Cited by 95
Yasumoto, K., Mukaida, N., Harada, A., Kuno, K., Akiyama, M., Nakashima, E., Fujioka, N., Mai, M., Kasahara, T., & Fujimoto-Ouchi, K. (1995) · PubMed · Cited by 88
Inhibition of Cyclooxygenase-2 by Celecoxib Reverses Tumor-Induced Wasting
Davis, T. W., Zweifel, B. S., O’Neal, J. M., Heuvelman, D. M., Abegg, A. L., Hendrich, T. O., & Masferrer, J. L. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.063099 · Cited by 88
Espat, N. J., Auffenberg, T., Rosenberg, J. J., Rogy, M. A., Martin, D., Fang, C., Hasselgren, P., Copeland, E. M., & Moldawer, L. L. (1996) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1996.271.1.r185 · Cited by 88
Myofiber degeneration/regeneration is induced in the cachecticApcMin/+mouse
Mehl, K. A., Davis, J. M., Berger, F. G., & Carson, J. A. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00778.2005 · Cited by 84
Self-citationSkeletal muscle metabolism in physiology and in cancer disease
Giordano, A. M., Calvani, M., Petillo, O., Carteni', M., Melone, M. A. B., & Peluso, G. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10601 · Cited by 81
Role of NF-κB and cytokine in experimental cancer cachexia
Zhou, W., Jiang, Z.-W., Tian, J., Jiang, J., Li, N., & Li, J.-S. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i7.1567 · Cited by 74
Soda, K., Kawakami, M., Kashii, A., & Miyata, M. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910620317 · Cited by 66
Brozek, W., Bises, G., Girsch, T., Cross, H., Kaiser, H., & Peterlik, M. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.07.014 · Cited by 62
Iwase, S., Murakami, T., Saito, Y., & Nakagawa, K. (2004) · PubMed · Cited by 60
CANCER CACHEXIA IS MEDIATED IN PART BY THE INDUCTION OF IL-6-LIKE CYTOKINES FROM THE SPLEEN
Barton, B. E., & Murphy, T. F. (2001) · Cytokine · doi:10.1006/cyto.2001.0968 · Cited by 58
Exercise, Cachexia, and Cancer Therapy: A Molecular Rationale
Ardies, C. M. (2002) · Nutrition and Cancer · doi:10.1207/s15327914nc422_1 · Cited by 57
Interleukin-6 does not activate protein breakdown in rat skeletal muscle
Garcia‐Martínez, C., López-Soriano, F. J., & Argilés, J. M. A. (1994) · Cancer Letters · doi:10.1016/0304-3835(94)90126-0 · Cited by 49
Nandrolone decanoate modulates cell cycle regulation in functionally overloaded rat soleus muscle
McClung, J. M., Mehl, K. A., Thompson, R. W., Lowe, L. L., & Carson, J. A. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00285.2004 · Cited by 46
Self-citationSopasakis, V. R., Larsson, B., Johansson, A., Holmäng, A., & Smith, U. (2004) · Diabetologia · doi:10.1007/s00125-004-1544-y · Cited by 45
Sepsis in mice stimulates muscle proteolysis in the absence of IL-6
Williams, A., Wang, J. J., Wang, L., Sun, X., Fischer, J. E., & Hasselgren, P.-O. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.6.r1983 · Cited by 44
Rethinking Nutritional Support for Persons with Cancer Cachexia
McCarthy, D. O. (2003) · Biological Research For Nursing · doi:10.1177/1099800403005001001 · Cited by 42
Cited by
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
Johnson, D. E., O'Keefe, R. A., & Grandis, J. R. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.8 · Cited by 3,110
Satellite Cells and the Muscle Stem Cell Niche
Yin, H., Price, F., & Rudnicki, M. A. (2013) · Physiological Reviews · doi:10.1152/physrev.00043.2011 · Cited by 2,166
Cancer Cachexia: Mediators, Signaling, and Metabolic Pathways
Fearon, K. C. H., Glass, D. J., & Guttridge, D. C. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.06.011 · Cited by 1,205
Tisdale, M. J. (2009) · Physiological Reviews · doi:10.1152/physrev.00016.2008 · Cited by 1,192
Intestinal Inflammation and Cancer
Ullman, T. A., & Itzkowitz, S. H. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.01.057 · Cited by 1,119
Metadata
- Authors
- Baltgalvis, K. A., Berger, F. G., Pena, M. M. O., Davis, J. M., Muga, S. J., & Carson, J. A.
- Venue
- American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Publisher
- American Physiological Society
- Published
- 2008-02
- Volume
- 294
- Issue
- 2
- Pages
- R393-R401
- ISSN
- 0363-6119 (ISSN-L)
- 1522-1490
- OpenAlex
- W2149953626
- Cited by
- 280
- References
- 45
- FWCI
- 5.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.